{"version":"1.0","type":"link","title":"Dose Escalation Trial of the Combination of Osimertinib and Quaratusugene Ozeplasmid Gene Therapy in Patients with Advanced NSCLC.","author_name":"Spira AI 외","author_url":"https://prs-insight.online/author/Spira%20AI","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/99330","thumbnail_width":1200,"thumbnail_height":630}